Otsuka Pharmaceutical and H. Lundbeck A/S announced Friday that their new medication Rexulti (brexpiprazole) had been approved by the Food and Drug Administration as an adjunctive treatment for major depressive disorder (MDD) and a treament for schizophrenia.
Over the same time period that multiple outbreaks of measles and whooping cough made headlines around the country, parents’ views on vaccines became more favorable, according to a poll by University of Michigan C.S. Mott Children's Hospital.
The National Association of Chain Drug Stores submitted a statement for the House Energy and Commerce Subcommittee on Health hearing titled “Medicaid at 50: Strengthening and Sustaining the Program” emphasizing the role pharmacy plays in providing convenient, accessible, and cost-effective health services to Medicaid beneficiaries.
The American Pharmacists Association Foundation has unveiled its new Patient Self-Management Solutions aimed at reducing overall cost of care by approximately $1,000 per person with diabetes per year, improving health outcomes and increasing patient satisfaction.